Skip to content

Compare

Injection vs Pill: Tirzepatide vs Oral Semaglutide

Last reviewed: September 2026Based on 3 clinical trials

Tirzepatide is Zepbound/Mounjaro (weekly injection). Oral semaglutide is Wegovy pill (daily pill). Here is how the two compare in clinical data.

Weight loss at maximum dose

No direct head-to-head trial between injection and pill. Tirzepatide from a 72-week trial; oral semaglutide from a 68-week trial.

Zepbound / Mounjaro(tirzepatide injection)20.9%(~50 lbs)
Oral Wegovy(semaglutide pill)16.6%(~40 lbs)
For a 240 lb person. Averages from separate studies. Individual results vary substantially.

Monthly cost self-pay

The oral pill is dramatically cheaper. With insurance, both are typically ~$25/month.

Oral Wegovy(semaglutide pill)$149–$299/mo
Zepbound(tirzepatide injection, via LillyDirect)$299–$449/mo
List prices and manufacturer self-pay programs. Insurance coverage varies.

A head-to-head trial exists — but not for these two. SURMOUNT-5 compared tirzepatide injection with semaglutide injection (not the pill). Tirzepatide produced 20.2% vs 13.7% for the injection. No trial directly compares tirzepatide injection with oral semaglutide pill.

Side effects comparison

From each drug's main weight loss trial. All stomach side effects are most common in the first 4–8 weeks and usually fade.

Nausea
Tirzepatide31%
Oral semaglutide44%
Diarrhea
Tirzepatide23%
Oral semaglutide18%
Vomiting
Tirzepatide18%
Oral semaglutide20%
Constipation
Tirzepatide12%
Oral semaglutide10%
Quit due to side effects
Tirzepatide6%
Oral semaglutide5%
Tirzepatide has lower nausea but higher diarrhea. Overall quit rates are similar (~5–6%). Both use slow dose escalation to minimize symptoms.

Beyond weight loss

Form

  • Tirzepatide — Once-weekly injection under the skin — no food timing restrictions
  • Oral semaglutide — Once-daily pill — requires 30-min fast before eating, no injection needed

Heart benefit

  • Semaglutide — 20% reduction in major heart events — proven in SELECT trial (17,604 adults)
  • Tirzepatide — Heart safety confirmed — benefit trial in progress

Side effects

  • Nausea (tirzepatide)~31%
  • Nausea (oral semaglutide)~44%
  • Quit due to side effects~7%

Usually peaks weeks 2–4, fades by week 8–12

The injection-vs-pill decision

The decision hinges on needle comfort, budget, and weight loss targets. Tirzepatide produces more weight loss through a dual-hormone mechanism, but requires weekly injections and costs roughly twice as much self-pay at the entry dose. Oral semaglutide is affordable (from $149/month), has proven heart protection, and avoids injections — but needs a 30-minute daily fast. Many people start with the pill and switch to the injection after 3–6 months if they want more weight loss.

Common questions

Written and maintained by one person · Built with agentic AI tools · Every number checked against the cited trial · Not medical advice

How this site is built →

Not sure where to start? Our 2-minute quiz can help.

Take the quiz →

Next step most people take

Built with agentic AI tools and not a substitute for medical advice

Last reviewed:

Was this page helpful?
Medical disclaimer: This website is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment. Prices shown are United States self-pay or list prices and vary by insurance and country.